We are interested in:
- Developing novel imaging probes for noninvasive assessment of specific biomarkers implicated in disease initiation, progression, or regression, and
- Exploring the translational roles of imaging probes and/or methodologies in clinical medicine practice with the ultimate goal to improve the outcome of patient care.